INTERPRETING YOUR LAB DATA - PowerPoint PPT Presentation

1 / 49
About This Presentation
Title:

INTERPRETING YOUR LAB DATA

Description:

New permits now have 8 minnows / 5 concentrations. Was the DO ... Fathead Minnow 12-30. Ceriodaphnia dubia 13-47. CONTROL (CV) RANGE. COEFFICIENTS OF VARIATION ... – PowerPoint PPT presentation

Number of Views:213
Avg rating:3.0/5.0
Slides: 50
Provided by: SEC1104
Category:

less

Transcript and Presenter's Notes

Title: INTERPRETING YOUR LAB DATA


1
INTERPRETING YOUR LAB DATA
2
TYPES OF LABORATORY REPORTS
  • ANALYTICAL
  • WHOLE EFFLUENT TOXICITY

3
INFORMATION COMMON TO ALL REPORTS
  • Title
  • Laboratory Name
  • Address, Phone, Contact
  • Unique Identifier (Laboratory Control No.)
  • Number of Pages
  • Client Name
  • Date of Receipt

4
SAMPLE SPECIFIC INFORMATION
  • Unique Sample Identifier
  • Sample ID
  • Sample Collection Date and Time

5
ANALYTICAL DATA - SAMPLE
  • Parameter
  • Analytical Method
  • Data
  • Units
  • Reporting Limit RL, MDL, PQL
  • Date of Analysis
  • Workgroup / Batch
  • Analyst

6
QUALITY CONTROL DATA
  • Laboratory Control Sample
  • Matrix Spike Sample
  • Sample Duplicate
  • Surrogates
  • Laboratory Blank

7
LABORATORY CONTROL SAMPLE
  • A sample matrix, free from the analytes of
    interest, spiked with verified known amounts of
    analytes or a material containing known and
    verified amounts of analyte. It is generally,
    used to establish intra-laboratory or analyst
    specific precision and bias or to assess the
    performance of all or a portion of the
    measurement system.

8
  • Frequency Minimum 1/batch
  • Individual LCS is compared to the acceptance
    criteria as published in the mandated test method
    or based upon three standard deviations around
    the mean
  • A LCS that is determined to be within the
    criteria effectively establishes that the
    analytical system is in control and validates
    system performance for the samples in the
    associated batch.

9
  • If a large number of analytes are in the LCS, it
    becomes statistically likely that a few will be
    outside the control limits. This may or may not
    indicate that the system is out of control.
  • Many laboratories have established Marginal
    Exceedances (ME) Limits. ME limits are between
    three or four standard deviations around the mean.

10
  • The number of marginal exceedances allowable is
    dependent upon the number of analytes in the LCS.
  • gt90 analytes, 5 ME
  • 71-90 analytes, 4 ME
  • 51-70 analytes, 3 ME
  • 31-50 analytes, 2 ME
  • 11-30 analytes, 1 ME
  • lt11 analytes, 0 ME allowed

11
MATRIX SPIKE
  • A sample prepared by adding a known amount of
    target analyte to a specified amount of matrix
    sample.
  • Matrix spikes are used to determine the effect of
    the matrix on recovery efficiency.

12
  • Theoretically, matrix spike control limits are
    typically equal to or greater than laboratory
    control sample limits.
  • If the matrix spike amount is less than four (4)
    times the result in the unspiked sample, the
    MS/MSD data may not represent the matrix effect.

13
SAMPLE DUPLICATE
  • Replicate aliquots of the same sample taken
    through the entire analytical procedure.
  • The results from the analysis indicate the
    precision of the results for the specific sample
    using the method selected and are expressed as
    relative percent difference (RPD).
  • Typically, RPD limits for sample duplicates gt RPD
    limits established from LSC/MS duplicates.

14
SURROGATES
  • Surrogates are used most often in organic
    chromatographic test methods and are chosen to
    reflect the chemistries of the targeted
    components of the method.
  • Added prior to sample preparation /extraction,
    they provide a measure of recovery for every
    sample matrix.

15
METHOD BLANK
  • A sample of a matrix similar to the batch of
    associated samples that is free from the analytes
    of interest and is processed simultaneously with
    and under the same conditions as samples through
    all steps of the analytical procedure, and in
    which no target analytes or interferences are
    present at concentrations that impact the
    analytical results for sample analyses.

16
  • Goal is to have no detectable contaminants.
  • Common method blank contaminates are acetone,
    methylene chloride, copper, iron, and zinc.

17
GENERAL GUIDANCE - BLANKS
  • If the sample contains the contaminant at levels
    of at least 10 times that in the blank, then the
    likely contribution to the sample from the
    contaminant in the laboratory environment is at
    most 10. The possible contamination is
    negligible

18
  • If the sample contains the contaminant at levels
    of at least 5 times but less than 10 times the
    blank result, the compound is probably present in
    the sample, but the numerical result should be
    considered an upper limit of the true
    concentration.

19
  • If the sample contains the contaminant at levels
    below 5 times the level in the blank, there is no
    adequate means by which to judge whether or not
    the sample result is attributable to laboratory
    contamination. The results for that compound in
    the sample then becomes unacceptable for
    compliance monitoring.

20
  • Parameter Relationships
  • CODgtBODgtTOC
  • BODgt CBOD
  • Total Solids TSS TDS
  • TKNgtNH3N
  • Total Nitrogen TKN NO3N NO2N
  • Total Organic Nitrogen TKN NH3N
  • OG gt TPH
  • Total Analytegt Dissolved Analyte
  • Cr Cr3 Cr6

21
SUPPLEMENT REPORT INFORMATION
  • Sample Receipt Documentation
  • Case Narrative
  • Data Qualifiers

22
SAMPLE RECEIPT DOCUMENTATION
  • Upon receipt, samples are inspected to determine
    if they meet regulatory compliance. If a sample
    fails to meet the requirements, the client should
    be contacted for instructions. If the decision
    is to proceed with the analysis, any sample
    failing to meet requirements must be
    appropriately flagged on the final report.

23
  • Temperature
  • Preservation
  • Holding Time
  • Container Information
  • Documentation (COC)

24
CASE NARRATIVE
  • Provides a correlation between field sample and
    laboratory sample numbers
  • Identifies any issues with sample receipt
  • Identifies extractions or analyses that are
    performed out of holding times

25
  • Deviations from the method
  • Identification of any QC failures and associated
    corrective actions taken by the laboratory
  • Any other factors that could affect the sample
    results (e.g., air bubbles in VOC sample vials,
    excess headspace, multi-phasic samples, container
    type or volume)

26
DATA QUALIFIERS
  • Data Qualifers are added by the laboratory during
    the review process
  • Data Qualifers are applied when measurement
    quality objects are not met and corrective action
    is not successful or when corrective action is
    not performed
  • They may also be applied to provided additional
    information concerning the reported data

27
  • B Analytes are detected in the blank above the
    reporting limit
  • J The analyte was positive the associated
    numerical value is the approximate concentration
    of the analyte in the sample
  • Q Data requires usability review due to the
    exceedance of method-specific holding time,
    calibration, or batch QC data associated with the
    sample does not meet measurement quality
    objectives
  • H Holding time was exceeded
  • W Data is presented on an as-received-basis

28
WHOLE EFFLUENT TOXICITY
29
INTRODUCTION
  • Permit Number
  • Toxicity Testing Requirement of Permit
  • Plant Location
  • Name of Receiving water body
  • Contract Laboratory
  • Objective of Test

30
PLANT OPERATONS
  • Products
  • Raw Materials
  • Operating Schedule
  • Description of waste treatment
  • Schematic of waste treatment
  • Retention time (if applicable)
  • Volume of waste flow
  • Design flow of treatment facility at time of
    sampling

31
Source of Effluent, Receiving Water and Dilution
Water
  • Effluent Samples
  • Sampling Point
  • Collection dates and times
  • Sample Collection method
  • Physical and chemical data
  • Mean daily discharge on sample collection date
  • Lapsed time from sample collection to delivery
  • Sample temperature when received at laboratory

32
  • Receiving Water Samples
  • Sampling point
  • Collection date and time
  • Sample collection method
  • Physical and chemical data
  • Streamflow
  • Sample temperature when received at lab
  • Lapsed time from sample collection to delivery

33
  • Dilution Water Samples
  • Source
  • Collection dates and times
  • Pretreatment
  • Physical and chemical characteristics

34
TEST METHOD
  • Toxicity test method used
  • Endpoints of test
  • Deviation from reference method
  • Date and time test started
  • Date and time test terminated
  • Type and volume of test chambers

35
  • Number of organisms per test
  • Number of replicate test chambers per treatment
  • Acclimation of test organisms
  • Test temperature
  • Specify if aeration was needed
  • Feeding Frequency, and amount and type of food
  • Specify if pH control measures were implemented

36
TEST ORGANISMS
  • Scientific name
  • Age
  • Life stage
  • Source

37
QUALITY CONTROL
  • Reference toxicant used routinely
  • Date and time of most recent reference toxicant
    test, test results, and current control chart
  • Dilution water used in reference toxicant test
  • Results (NOEC or where applicable, LOEC, LC50,
    EC50, IC25 and/or IC50)
  • Report Percent Minimum Significant Difference
    (PMSD) calculated for sublethal endpoints
    determined by hypothesis testing in reference
    toxicant test
  • Physical and chemical methods used.

38
RESULTS
  • Provide raw toxicity data in tabular form,
    including daily records of affected organisms in
    each concentration (including controls) and
    replicate, and in graphical form (plots of
    toxicity data)
  • Provide table of LC50s, NOECs, IC25, IC50, etc
    (as required in applicable NPDES permit)
  • Indicate statistical methods used to calculate
    endpoints

39
  • Provide summary table of physical and chemical
    data
  • Tabulate QA data
  • Provide percent minimum significant differences
    (PMSD) calculated for sublethal endpoints.
  • Relationship between test endpoints and permit
    limits
  • Actions to be taken (if any)

40
GLOSSARY
  • Effect Concentration (EC) is a point estimate of
    the toxicant concentration that would cause an
    observable adverse effect in a given percent of
    the test organisms. EC25 is a point estimate of
    the toxicant concentration that would cause an
    observable adverse effect in 25 percent of the
    test organism

41
  • Inhibition Concentration (IC) is a point estimate
    of the toxicant concentration that causes a
    percent reduction in a non-lethal biological
    measurement (reproduction and growth), calculated
    from a continuous model. IC25 is a point
    estimate of the toxicant that would cause a 25
    reduction in a non-lethal biological measurement.
  • LC50 (lethal concentration, 50) is the toxicant
    or effluent concentration that would cause death
    in 50 percent of organisms.

42
  • Lowest Observed Effect Concentration (LOEC) is
    the lowest concentration of an effluent or
    toxicant that results in adverse effects on the
    test organisms.
  • No Observed Effect Concentration (NOEC) is the
    highest test concentration of an effluent or
    toxicant that causes no observable adverse effect
    on the organism
  • Percent Minimum Significant Difference (PMSD)
    allows comparison of different tests and
    represents the smallest significant difference
    from the control as a percentage of the control
    mean that can be measured.

43
GUIDANCE FOR REVIEWING BIOMONITORING REPORTS
44
  • Were all samples chilled to 4oC during and/or
    immediately after collection and maintained at
    just above freezing.
  • When reviewing the holding times the maximum
    holding time of effluents is 36 hours and samples
    should not be used for renewals if older than 72
    hours.

45
  • Was the dilution series used in the test as
    specified in the permit?
  • Does the laboratory have your latest permit?
  • Fathead Minnows tests use to be a series of 10
    minnows /4 concentrations. New permits now have
    8 minnows / 5 concentrations.
  • Was the DO acceptable for the test gt4 but lt9?

46
  • Was chlorine present in the receiving water ?
  • Was the sample brought to the correct temperature
    prior to starting the analysis?
  • Was the control and sample handled in exactly the
    same manner. (Example Treated for the same
    interferences (UV / antibiotic)?
  • Was the critical dilution reported the same as
    that listed in the permit?

47
  • Was the Coefficient of Variation (CV) in the
    control and the critical dilution lt40.
  • Fathead Survival in control must be at least
    80. The average dry weight per surviving control
    larvae at the end of the test must equal or
    exceed of 0.25 mg.
  • Ceriodaphnia dubia Test result acceptable, at
    least 80 of all control organisms must survive,
    and 60 of surviving control females must produce
    at least three broods, with an average of 15 or
    more young per surviving female.

48
VARIABILITY CRITERIA FOR SUBLETHAL HYPOTHESIS
(Upper and Lower PMSD)
  • Fathead Minnow 12-30
  • Ceriodaphnia dubia 13-47

49
CONTROL (CV) RANGECOEFFICIENTS OF VARIATION
  • Fathead 3.5 to 20 Minnow (0.035-0.2)
  • Ceriodaphnia 8.9 to 42
  • dubia (0.089 to 0.42)
Write a Comment
User Comments (0)
About PowerShow.com